Chemoinformaics analysis of Bis(1-methyl thio)propyl disulfide
| Molecular Weight | 242.5 | nRot | 7 |
| Heavy Atom Molecular Weight | 224.356 | nRig | 0 |
| Exact Molecular Weight | 242.029 | nRing | 0 |
| Solubility: LogS | -4.276 | nHRing | 0 |
| Solubility: LogP | 3.76 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 36.9623 |
| nHD | 0 | BPOL | 25.4377 |
| QED | 0.474 |
| Synth | 4.884 |
| Natural Product Likeliness | 0.544 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.116 |
| HIA | 0.036 |
| CACO-2 | -4.882 |
| MDCK | 0.00000545 |
| BBB | 0.27 |
| PPB | 0.941863 |
| VDSS | 1.82 |
| FU | 0.0263805 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.888 |
| CYP2c19-inh | 0.592 |
| CYP2c19-sub | 0.886 |
| CYP2c9-inh | 0.535 |
| CYP2c9-sub | 0.577 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.685 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.396 |
| CL | 12.931 |
| T12 | 0.324 |
| hERG | 0.005 |
| Ames | 0.003 |
| ROA | 0.034 |
| SkinSen | 0.571 |
| Carcinogencity | 0.887 |
| EI | 0.824 |
| Respiratory | 0.057 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.932137 |